These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38982153)

  • 1. Pan-cancer analysis and the oncogenic role of Glypican 1 in hepatocellular carcinoma.
    Cao L; Li F; Cai S; Zhang J; Guo C; Ali S; Zhou J; Jing X; Wang X; Qin Y; Wu F
    Sci Rep; 2024 Jul; 14(1):15870. PubMed ID: 38982153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma.
    Wang L; Yao M; Pan LH; Qian Q; Yao DF
    Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):361-6. PubMed ID: 26256079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulated lncRNA TP73-AS1 reduces radioresistance in hepatocellular carcinoma via the PTEN/Akt signaling pathway.
    Song W; Zhang J; Xia Q; Sun M
    Cell Cycle; 2019 Nov; 18(22):3177-3188. PubMed ID: 31564201
    [No Abstract]   [Full Text] [Related]  

  • 4. Distinct diagnostic and prognostic values of Glypicans gene expression in patients with hepatocellular carcinoma.
    Wang JY; Wang XK; Zhu GZ; Zhou X; Yao J; Ma XP; Wang B; Peng T
    BMC Cancer; 2021 Apr; 21(1):462. PubMed ID: 33902495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the study of oncofetal antigen glypican-3 expression in HBV-related hepatocellular carcinoma.
    Yao M; Wang L; Fang M; Zheng W; Dong Z; Yao D
    Biosci Trends; 2016 Nov; 10(5):337-343. PubMed ID: 27795482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma.
    Liu Z; Wang Y; Dou C; Sun L; Li Q; Wang L; Xu Q; Yang W; Liu Q; Tu K
    J Exp Clin Cancer Res; 2018 Mar; 37(1):49. PubMed ID: 29510736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA PICSAR/miR-588/EIF6 axis regulates tumorigenesis of hepatocellular carcinoma by activating PI3K/AKT/mTOR signaling pathway.
    Liu Z; Mo H; Sun L; Wang L; Chen T; Yao B; Liu R; Niu Y; Tu K; Xu Q; Yang N
    Cancer Sci; 2020 Nov; 111(11):4118-4128. PubMed ID: 32860321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulating glypican-3 expression: molecular-targeted therapy for hepatocellular carcinoma.
    Dong Z; Yao M; Wang L; Yang J; Yao D
    Mini Rev Med Chem; 2014; 14(14):1183-93. PubMed ID: 25553423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted glypican-3 gene transcription inhibited the proliferation of human hepatoma cells by specific short hairpin RNA.
    Yu D; Dong Z; Yao M; Wu W; Yan M; Yan X; Qiu L; Chen J; Sai W; Yao D
    Tumour Biol; 2013 Apr; 34(2):661-8. PubMed ID: 23192642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New tumor suppressor microRNAs target glypican-3 in human liver cancer.
    Cartier F; Indersie E; Lesjean S; Charpentier J; Hooks KB; Ghousein A; Desplat A; Dugot-Senant N; Trézéguet V; Sagliocco F; Hagedorn M; Grosset CF
    Oncotarget; 2017 Jun; 8(25):41211-41226. PubMed ID: 28476031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA‑9‑5p downregulates Klf4 and influences the progression of hepatocellular carcinoma via the AKT signaling pathway.
    Dong X; Wang F; Xue Y; Lin Z; Song W; Yang N; Li Q
    Int J Mol Med; 2019 Mar; 43(3):1417-1429. PubMed ID: 30664155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target.
    Chen H; Wong CC; Liu D; Go MYY; Wu B; Peng S; Kuang M; Wong N; Yu J
    Theranostics; 2019; 9(18):5246-5260. PubMed ID: 31410213
    [No Abstract]   [Full Text] [Related]  

  • 13. Pan-cancer analysis of DCTN2 and its tumour-promoting role in HCC by modulating the AKT pathway.
    Xu S; Xing J; Li K; Qiao L; Zhang C; Ren Y; Liu Y
    J Cell Mol Med; 2024 Jun; 28(11):e18450. PubMed ID: 38842133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. As a downstream target of the AKT pathway, NPTX1 inhibits proliferation and promotes apoptosis in hepatocellular carcinoma.
    Zhao Y; Yu Y; Zhao W; You S; Feng M; Xie C; Chi X; Zhang Y; Wang X
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31113871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncofetal antigen glypican-3 as a promising early diagnostic marker for hepatocellular carcinoma.
    Yao M; Yao DF; Bian YZ; Zhang CG; Qiu LW; Wu W; Sai WL; Yang JL; Zhang HJ
    Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):289-94. PubMed ID: 21669573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma.
    Yang YF; Zhang MF; Tian QH; Fu J; Yang X; Zhang CZ; Yang H
    Mol Cancer; 2018 Aug; 17(1):117. PubMed ID: 30089483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
    Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
    Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma.
    Zhang ZQ; Chen J; Huang WQ; Ning D; Liu QM; Wang C; Zhang L; Ren L; Chu L; Liang HF; Fan HN; Zhang BX; Chen XP
    Mol Oncol; 2019 Apr; 13(4):792-810. PubMed ID: 30556279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.